摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-bromo-2-(3,4-difluorophenyl)-4-(3-hydroxy-3-methylbutoxy)-2H-pyridazin-3-one | 266320-84-7

中文名称
——
中文别名
——
英文名称
5-bromo-2-(3,4-difluorophenyl)-4-(3-hydroxy-3-methylbutoxy)-2H-pyridazin-3-one
英文别名
5-Bromo-2-(3,4-difluorophenyl)-4-(3-hydroxy-3-methylbutoxy)pyridazin-3(2H)-one;5-bromo-2-(3,4-difluorophenyl)-4-(3-hydroxy-3-methylbutoxy)pyridazin-3-one
5-bromo-2-(3,4-difluorophenyl)-4-(3-hydroxy-3-methylbutoxy)-2H-pyridazin-3-one化学式
CAS
266320-84-7
化学式
C15H15BrF2N2O3
mdl
——
分子量
389.197
InChiKey
ISHPREYNSKNEND-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    23
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    62.1
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    An Efficient Multikilogram Synthesis of ABT-963:  A Selective COX-2 Inhibitor
    摘要:
    An efficient chemical process for the multikilogram synthesis of ABT-963 ( 3) is described. The potent and selective COX-2 inhibitor was prepared in four steps in 36% overall isolated yield from commercially available 3,4-difluoroaniline ( 4). The chemistry, which required no chromatography, involved a facile one-pot synthesis of the pyridazinone core, a selective alkoxylation, a high yielding Suzuki coupling, and a very efficient oxidation.
    DOI:
    10.1021/op060016v
  • 作为产物:
    描述:
    参考文献:
    名称:
    An Efficient Multikilogram Synthesis of ABT-963:  A Selective COX-2 Inhibitor
    摘要:
    An efficient chemical process for the multikilogram synthesis of ABT-963 ( 3) is described. The potent and selective COX-2 inhibitor was prepared in four steps in 36% overall isolated yield from commercially available 3,4-difluoroaniline ( 4). The chemistry, which required no chromatography, involved a facile one-pot synthesis of the pyridazinone core, a selective alkoxylation, a high yielding Suzuki coupling, and a very efficient oxidation.
    DOI:
    10.1021/op060016v
点击查看最新优质反应信息

文献信息

  • [EN] PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS<br/>[FR] INHIBITEURS DE LA BIOSYNTHESE DE LA PROSTAGLANDINE ENDOPEROXYDE H SYNTHASE
    申请人:ABBOTT LAB
    公开号:WO2000024719A1
    公开(公告)日:2000-05-04
    The present invention describes pyridazinone compounds of formula (I) which are cyclooxygenase (COX) inhibitors, and in particular, are selective inhibitors of cyclooxygenase-2 (COX-2). COX-2 is the inducible isoform associated with inflammation, as opposed to the constitutive isoform, cyclooxygenase-1 (COX-1) which is an important 'housekeeping' enzyme in many tissues, including the gastrointestinal (GI) tract and the kidneys. The selectively of these compounds for COX-2 minimizes the unwanted GI and renal side-effects seen with currently marketed non-steroidal anti-inflammatory drugs (NSAIDs).
    本发明描述了式(I)的吡啶酮化合物,它们是环氧合酶(COX)抑制剂,特别是选择性抑制剂环氧合酶-2(COX-2)。COX-2是与炎症有关的诱导型同工酶,而非构成型同工酶环氧合酶-1(COX-1),后者是许多组织(包括胃肠道和肾脏)中重要的“管家”酶。这些化合物对COX-2的选择性最小化了目前市场上非甾体类抗炎药(NSAIDs)所见的不良胃肠道和肾脏副作用。
  • Prostaglandin endoperoxide H synthase biosynthesis inhibitors
    申请人:——
    公开号:US20020028938A1
    公开(公告)日:2002-03-07
    The present invention describes pyridazinone compounds of formula I 1 which are cyclooxygenase (COX) inhibitors, and in particular, are selective inhibitors of cyclooxygenase-2 (COX-2). COX-2 is the inducible isoform associated with inflammation, as opposed to the constitutive isoform, cyclooxygenase-1 (COX-1) which is an important “housekeeping” enzyme in many tissues, including the gastrointestinal (GI) tract and the kidneys. The selectivity of these compounds for COX-2 minimizes the unwanted GI and renal side-effects seen with currently marketed non-steroidal anti-inflammatory drugs (NSAIDs).
    本发明描述了公式I1的吡啶并咪唑酮化合物,它们是环氧合酶(COX)抑制剂,特别是选择性地抑制环氧合酶-2(COX-2)。 COX-2是与炎症相关的可诱导异构体,与包括胃肠道和肾脏在内的许多组织中重要的“家务”酶环氧合酶-1(COX-1)相对。这些化合物对COX-2的选择性最小化了目前市场上非甾体抗炎药(NSAIDs)所见的不良胃肠和肾脏副作用。
  • Org. Process Res. Dev. 2006, 10, 512-517
    作者:
    DOI:——
    日期:——
  • PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS
    申请人:ABBOTT LABORATORIES
    公开号:EP1124804B1
    公开(公告)日:2005-08-24
  • US6307047B1
    申请人:——
    公开号:US6307047B1
    公开(公告)日:2001-10-23
查看更多